Back to Nuveen, LLC Nuveen, LLC

REGNREGN
6 quarters

Position history for Nuveen, LLCNuveen, LLC's holdings in REGENERON PHARMACEUTICALS

Nuveen, LLC holds 2M shares of REGN (REGENERON PHARMACEUTICALS), worth $1.3B as of 2026-Q2. The position was decreased (-2.2% shares). REGN represents 0.3% of Nuveen, LLC's portfolio.

Current Value

$1.3B

Current Shares

2M

Total Value Change

+$915.8M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2M
-2.2%
$1.3B0.3%$622.81
0
2026-Q1
Increased
2.1M
+2.7%
$1.6B0.4%$770.59
39
2025-Q4
Increased
2M
+71.1%
$1.6B0.4%$768.90
57
2025-Q3
Increased
1.2M
+39.7%
$660.8M0.2%$559.40
50
2025-Q2
Increased
841,549
+55.3%
$441.8M0.1%$521.53
53
2025-Q1
New
542,018
-
$343.8M0.1%$629.11
51

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used